E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/19/2022 in the Prospect News Structured Products Daily.

New Issue: UBS sells $500,000 step down trigger autocallable notes on Merck, Microsoft, Apple

By William Gullotti

Buffalo, N.Y., July 19 – UBS AG, London Branch priced $500,000 of step down trigger autocallable notes due Jan. 9, 2025 linked to the least performing of the stocks of Apple Inc., Merck & Co., Inc. and Microsoft Corp., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will be called at par plus a 13.5% annualized call premium if each stock closes at or above its call level on any quarterly valuation date after six months. Call level starts at 100% of initial level and decreases by 3% with each subsequent valuation date.

The notes will be called at par plus the 40.5% final premium of all three stocks close above their 70% downside threshold levels on the final call date.

If any stock finishes below its downside threshold, investors will receive a number of shares of the worst performer equal to $1,000 divided by that stock’s initial level.

UBS Securities LLC and UBS Investment Bank are the agents.

Issuer:UBS AG, London Branch
Issue:Step down trigger autocallable notes
Underlying stocks:Apple Inc., Merck & Co., Inc., Microsoft Corp.
Amount:$500,000
Maturity:Jan. 9, 2025
Coupon:0%
Price:Par
Payout at maturity:Par plus 40.5% unless any stock finishes below downside threshold level, in which case investors will receive a number of shares of the worst performer equal to its equity ratio
Call:At par plus a 13.5% annualized call premium if each stock closes at or above its call level on any quarterly valuation date after six months; call level starts at 100% of initial level and decreases by 3% with each subsequent valuation date
Initial levels:$179.70 for Apple, $329.01 for Microsoft, $77.01 for Merck
Downside thresholds:$125.79 for Apple, $230.31 for Microsoft, $53.91 for Merck; 74% of initial levels
Equity ratios:5.5648 for Apple, 3.0394 for Microsoft, 12.9853 for Merck; share delivery per note
Pricing date:Jan. 4
Settlement date:Jan. 7
Agents:UBS Securities LLC and UBS Investment Bank
Fees:0.25%
Cusip:90279DTS5

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.